Proactive - Interviews for investors

Emyria Ltd (ASX:EMD) CEO Michael Winlo sits down with Proactive’s Jonathan Jackson to discuss significant advancements in the company's mental health initiatives. Emyria recently opened the Empax Centre, a cutting-edge facility aimed at enhancing mental health treatments, including MDMA-assisted therapy for PTSD.

Emyria’s ambitious vision is showcased by this centre, targeting care gaps in resistant PTSD, with sights set on operational profitability and global expansion. Winlo discusses how the technology employed at the Empax Centre enhances patient care as well as Emyria’s plans to broaden its therapeutic offerings.

Significant progress has also been made with the expansion of Emyria’s authorised prescriber team. The addition of a second psychiatrist as an authorised prescriber underlines Emyria’s commitment to advancing mental health care, aligning with its expansion efforts.

Emyria is also collaborating with charity Reach Wellness and this partnership signifies a strategic step towards validating Emyria’s MDMA-assisted therapy model, aiming to improve PTSD treatment for first responders. This collaboration, backed by significant fundraising, is pivotal for demonstrating the model’s safety, effectiveness and scalability.

#ProactiveInvestors #Emyria #ASX #biotech #Pharma #EmpaxCentre #PTSD

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Alderan Resources Ltd (ASX:AL8) managing director Scott Caithness joins Jonathan Jackson in the Proactive studio to discuss the company's latest activities in lithium and copper.

Beginning with Alderan’s work in Brazil’s Lithium Valley, Caithness talks through a significant sampling program, which is now more than 50% complete. The MD shares insights on the ongoing work and findings, with initial assay results anticipated in mid-April and the program wrapping up in early May. He also explains Alderan's next strategic steps in this region.

Meanwhile, in Utah, preparations for drilling the New Years copper prospect in the Frisco area are advancing quickly, with drilling set to start this quarter. The precise locations and orientation of a planned three-hole diamond drilling program are being finalised .

Alderan already has drill sites permitted in the Frisco project area, however this will require amendment for the new locations which is expected to be a shorter process than permitting new drill sites in the area.

Caithness delivers a comprehensive update on the expected timeline for results and ongoing projects and sheds light on Alderan's strategic direction and upcoming developments.

#ProactiveInvestors #AlderanResources #ASX #Lithium #Copper #CriticalMinerals

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

CuFe Ltd (ASX:CUF) executive director Mark Hancock sits down with Proactive’s Jonathan Jackson to share insights about the promising outcomes of a comprehensive soil geochemical program and the strategic Heritage Protection Agreement ahead of drilling at the North Dam Project.

Hancock discusses the geochemical results, which have not only broadened the scope of lithium oxide anomalies but also sharpened the focus for the initial drilling stage. This development signifies a leap forward in CuFe's exploration efforts, bolstering the company's prospects in identifying viable lithium resources.

The partnership with Marlinyu Ghoorlie Native Title Claimant Group through a Heritage Protection Agreement was highlighted as a pivotal step, ensuring exploration activities proceed respectfully and beneficially for both parties. This collaboration underscores the importance of local support and the mutual advantages of sustainable and responsible resource development.

With heritage surveys pending, CuFe anticipates starting its drilling operations this quarter, aiming to unveil the potential of a significant lithium system in the Spargoville and North Dam region. Hancock points out the active exploration by various junior and major companies in the area, which underscores the region's mineral potential.

Hancock also talks through the company’s copper and iron ore projects and the news expected to flow from those.

#ProactiveInvestors #CuFe #ASX #CriticalMinerals #Lithium #NorthDamProject

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Kingston Resources Ltd (ASX:KSN) CEO Andrew Corbett sits down with Proactive’s Jonathan Jackson to discuss updated assay information from recent resource definition drilling at Mineral Hill’s underground mine, intercepting individual grades as high as 25.03 g/t gold, 295 g/t silver, 6.45% copper, 29.7% lead and 34.71% zinc. Drilling was designed as infill in areas of potential early production and extension to the northwest.

Corbett also discusses the completion of the $8.8 million institutional segment of the company’s $13.5 million capital raise, which includes a $8.1 million private placement and a $730,000 accelerated component. This move saw about 135.7 million new shares issued at $0.065 each, setting the stage for the next phase of funding.

The capital injection is earmarked for advancing Kingston’s strategic initiatives, notably the development of the Misima Gold Project in Papua New Guinea and continued operations at the Mineral Hill mine in New South Wales. These projects are integral to Kingston's ambition to become a mid-tier entity in the gold and base metals sector.

#ProactiveInvestors #KingstonResources #ASX #Gold #MineralHill #MisimaGoldProject #BaseMetals

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Lumos Diagnostics Holdings Ltd (ASX:LDX) CEO Doug Ward sits down with Jonathan Jackson to explore the company's innovative point-of-care diagnostic solutions. Lumos, known for its proprietary Lumos-branded diagnostic tests, has been making strides in healthcare technology, particularly with its FebriDx device, designed to revolutionise healthcare settings.

Ward provides an insight into Lumos’ diverse technology and product suite, focusing on the FebriDx device's role in diagnosing and managing Acute Respiratory Infections (ARIs) efficiently. The discussion looks at the regulatory achievements and commercial trajectory of FebriDx on a global scale, highlighting the strategic advancements Lumos has made in the diagnostics field.

Ward discusses the latest study published in the Infectious Diseases and Clinical Microbiology journal, which evaluated FebriDx’s efficacy in pediatric care. Conducted at Sant Joan de Déu Hospital in Barcelona, the study involved 216 paediatric patients and underscored FebriDx’s potential to optimise antibiotic usage in children with febrile respiratory infections. According to the study, FebriDx not only refines antibiotic administration but also reduces the reliance on chest X-rays, marking a significant step forward in managing paediatric febrile illnesses more effectively and safely.

#ProactiveInvestors #LumosDiagnostics #ASX #biotech #FebriDx

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Suvo Strategic Minerals Ltd (ASX:SUV) non-executive chairman Aaron Banks joins Proactive’s Jonathan Jackson to discuss the latest developments with Colliecrete. Banks outlines Suvo’s collaboration with Dowsing Group on the Bunbury Outer Ring Road Project in Western Australia and talks about how Colliecrete can play a crucial role in reducing carbon emissions by 50-70%, showcasing its potential to change future construction practices.

Banks also sheds light on the ideal markets for Suvo’s geopolymer concrete, and the strategic additions of Peter Snowsill and Martin Anda to the team, enhancing Suvo’s expertise and vision.

“We welcome Peter to the team to help progress the MoUs with Dowsing Group and PERMAcast as well as prioritise the almost daily inquiries we’re now receiving on our low carbon geopolymer concrete,” Banks said in Suvo’s recent announcement.

“Securing a strategically located site to commence trial pours of Colliecrete in preparation for the BORR demonstration pour, is another step forward and we thank Peel for offering their land and services. We look forward to updating the market once we have commenced trial pours of our low-carbon concrete.”

Finally, Banks looks at what investors can expect from the company in the next 90 days.

#ProactiveInvestors #SuvoStrategicMaterials #ASX #tech #Colliecrete

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Trust Stamp President Andrew Gowasack joined Steve Darling from Proactive to revealed a fast-tracked implementation of a solution tailored for financial institutions and other enterprises currently utilizing voice recognition technologies or accepting voice instructions via telephone calls.

Gowasack the development of this solution was significantly influenced by feedback from the financial sector, especially highlighted by the ICBA ThinkTECH Accelerator program. Trust Stamp engaged with dozens of banks across the United States, identifying wire fraud as a prevalent challenge. The company's response, a seamlessly integrated solution, showcases its commitment to leveraging technology in the fight against fraud.

The threat landscape has evolved with the advent of AI, making traditional security measures inadequate. Gowasack shared insights into how AI and deep fake technologies have been used to circumvent existing security protocols, emphasizing the importance of innovative solutions in this new era of digital security.

Trust Stamp's approach, focusing on ease of use and effectiveness, involves a simple authentication process that enhances security without detracting from the customer experience. This balance is crucial as financial institutions navigate the twin challenges of combating fraud and maintaining customer satisfaction.

With three banks in the final stages of internal approval for Trust Stamp's solution, the company is poised to play a pivotal role in transforming financial security. This initiative reflects a broader industry recognition of the need for advanced solutions to address the sophisticated threats facing financial institutions today.

#proactiveinvestors #truststamp #nasdaq #idai #globalsecure #datasecurity #privacyprotection #pertnership

#FinancialFraudPrevention, #FraudProtection, #BankingInnovation, #DeepFakeSecurity, #WireFraud, #AIinBanking, #FinancialSecurity, #CyberSecurity, #BankingTech, #InnovationInBanking, #AIForFraudPrevention, #SecureBanking, #TechInFinance, #DigitalBankingSolutions, #FraudPreventionTech, #BankingSolutions, #FinancialTechnology, #FinTechInnovation, #CyberFraudPrevention, #BankTech, #DigitalSecurity, #FinancialInstitutionsSecurity, #AntiFraudSolutions, #BankingSecurity#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Pantheon Resources Executive Chairman David Hobbs and Technical Director Bob Rosenthal joined Steve Darling from Proactive to announce the results of the updated Independent Expert Report by Netherland Sewell & Associates (NSAI) concerning approximately 43,000 acres of leases on the 100% owned Kodiak Field on the North Slope of Alaska, acquired by the company in December 2023.

According to the report, NSAI's best estimates of Kodiak's contingent recoverable resources amount to 1.2 billion barrels of marketable liquids and 5.4 trillion cubic feet of gas. This represents a 25% increase in recoverable marketable liquids compared to NSAI's previous 2023 report. Kodiak is identified as a large basin floor fan accumulation with three well penetrations, and recent drilling activity and acreage acquisition strategy have focused on moving structurally higher into better reservoir rocks, improving porosity and permeability.

The potential improvement in reservoir quality in the newly acquired acreage underpins a 40% increase in the high estimate of recoverable resources to 2,840 million barrels of marketable liquids and 11.75 trillion cubic feet of natural gas.

The Kodiak oil and gas field is currently Pantheon's largest project development candidate, defined by three well penetrations into the Basin Floor Fan structure, which extends over 10 miles from the deepest part of the fan to the 2021 updip Theta West-1 appraisal well. The recent successful lease bids secure the remainder of the accumulation to the northwest and add a significant volume of recoverable oil and gas to the Kodiak field. Pantheon has delineated the full extent of the field through its proprietary 3D seismic, with seismic attributes indicating the presence of light oil across the entirety of the field.

#proactiveinvestors #pantheonresourcesplc #mining #lse #panr #pthrf

#FundingNews #AssetExpansion #OilandGasIndustry #CEOInterview #EnergyInvestments #ResourceExploration #DynamicModeling #ShelfMarginDeltaic #KodiakProject, #EnergyExploration, #OilAndGas, #EnergySector, #NaturalResources, #MarketAnalysis, #InvestmentOpportunity, #SustainableEnergy, #ResourceManagement, #TechInnovation, #GasExploration, #OilFields, #AlaskaEnergy, #InvestorInsights, #EnergyProduction, #CorporateStrategy, #EnergyEconomics, #ReservoirEngineering, #EnvironmentalStewardship, #StrategicPartnerships, #EnergyDevelopment, #ProjectValidation, #EnergyIndustry, #DevelopmentDrilling

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's medical devices, which are capable of enhancing the human airway and potentially eliminating sleep apnea symptoms after a 12-month treatment period. This FDA clearance positions Vivos as the only line of oral medical devices globally that can treat severe sleep apnea.

The approval for Medicare reimbursement is described as a monumental achievement, as it is expected to benefit tens of millions of Medicare patients suffering from moderate to severe obstructive sleep apnea (OSA) without the need for lifetime intervention. This recognition by the Centers for Medicare and Medicaid Services (CMS) propels Vivos's devices as a viable alternative to traditional CPAP treatments, especially timely given the recent recalls in the CPAP market and Philips' withdrawal from the U.S. market.

Huntsman expressed his excitement about the broader implications of this approval, including increased recommendations of Vivos's treatments by medical and dental providers and a growing awareness of their efficacy as an alternative to CPAP treatments. This development represents a significant step forward in transforming patient care for individuals suffering from sleep apnea.

Watch the full interview to learn more about Vivos Therapeutics Inc.'s pioneering approach to treating sleep apnea and their vision for improving patient care.

#proactiveinvestors #vivostherapeuticsinc #nasdaq #vvos #biopharma

#SleepApneaSolutions, #MedicareReimbursement, #OralDeviceTherapy, #HealthTechInnovation, #FDAApproval, #AirwayEnhancement, #CPAPAlternative, #BreathingDisorders, #MedicalDeviceTech, #SleepQualityImprovement, #SevereOSATreatment, #TherapeuticDevices, #SleepDisorderCare, #LifetimeTreatment, #SleepWellness, #RespiratoryHealth, #PatientCareInnovation, #MedTechNews, #SleepApneaAwareness, #DentalMedicine, #AirwayHealth, #InnovativeMedicine, #SleepTherapeutics, #BreathBetter

ARway.ai Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to unveil two new Software as a Service (SaaS) developer deals with prominent companies in Saudi Arabia and Spain. These agreements underscore ARway.ai's dedication to advancing spatial computing across diverse sectors and applications, solidifying its status as a frontrunner in augmented reality (AR) technology integration.

Gappelberg highlighted to Proactive that ARway.ai has surpassed 3,700 subscribers, achieving a remarkable 200% quarter-over-quarter growth in developer deals with a total of 58 secured agreements. Additionally, the company experienced a 100% increase quarter-over-quarter in partner deals, with a total of 7 collaborations established.

Furthermore, ARway.ai announced a successful start to its new student plan subscriptions, securing partnerships with universities globally, including University College Cork in the UK and the German University of Technology in Oman. This positive development follows the recent news in March, which saw several student plan subscriptions from institutions such as Bicol University, DHA Suffa University, and the University of Alberta.

These collaborations signify a surge in the adoption and acknowledgment of ARway's platform within educational and research contexts, reflecting a growing interest from educators, students, and researchers in the potential of extended reality (XR)/AR technologies.

#proactiveinvestors #arwaycorporation #cse #arwy.ai #otc #arwyf #wayfinding

#IndoorNavigation, #TechInnovation, #EvanGappelberg, #Technology, #NavigationTech, #DeveloperCommunity, #GlobalTech, #TechPartnerships, #AugmentedReality, #ARtech, #StartupGrowth, #TechUpdate, #InnovationInTech, #EmergingTechnologies, #TechTrends, #SpatialComputing, #RealEstateTech, #UniversityPartnerships, #EnterpriseTech, #SaudiArabiaTech, #SpainTech, #UAEtech, #PioneeringTechnology, #TechAdoption#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews